Subscribe: MedPage Today Product Alert
Added By: Feedage Forager Feedage Grade A rated
Language: English
approved  cancer drug  cancer  device  drug  fda approved  fda oks  fda  kids  oks  product  treatment  washington fda  washington 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: MedPage Today Product Alert

MedPage Today Product Alert

Physicians...get the latest breaking news on Product Alerts. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals.

Published: Tue, 23 Oct 2012 13:20:13 -0400

Copyright: Copyright 2012 MedPage Today.

Lung Cancer: Expanded Alimta Label

Fri, 19 Oct 2012 15:00:00 -0400

WASHINGTON -- The FDA has expanded the indication for the cancer drug pemetrexed injection to act as a maintenance therapy with cisplatin for nonsquamous non-small cell lung cancer.

Jetrea Gets FDA Nod for Macular Adhesion

Fri, 19 Oct 2012 12:00:00 -0400

WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.

Kids at Risk for Soap 'Pod' Poisoning

Fri, 19 Oct 2012 11:00:00 -0400

Detergent packaged in single-load 'pods' are time-saving, but are also attractive to children who mistake the pods for treats, making this laundry aid a poisoning risk.

Under-the-Skin ICD Gets FDA Green Light

Fri, 28 Sep 2012 17:46:02 -0400

WASHINGTON -- The FDA has approved the first subcutaneous implantable cardioverter-defibrillator (S-ICD).

Spirometry: There's an App for That, Too

Fri, 28 Sep 2012 14:00:00 -0400

A patient at the University of Pennsylvania Health System's Lung Center and a paramedic have developed a digital spirometry app to monitor pulmonary function from home on an iPhone.

FDA Panel to Review Safety of Eye Device

Wed, 26 Sep 2012 16:58:35 -0400

WASHINGTON -- FDA reviewers expressed concern over the long-term safety of what could be the first retinal prosthesis device despite evidence that it helps improve the vision of some patients.

Device Stops Asthmatic Kids' Inhaler Woes

Tue, 25 Sep 2012 15:00:00 -0400

An investigational device could let kids with asthma take their daily controller medications while they sleep, avoiding difficulties many children have with inhalers and nebulizers.

Suboxone Maker Pulls Pills in Favor of Film

Tue, 25 Sep 2012 13:30:00 -0400

The buprenorphine-naloxone combination product (Suboxone) in sublingual tablet form will soon be pulled from the U.S. market because its child-resistant packaging isn't effective enough.

FDA Warns About GI Product

Wed, 19 Sep 2012 15:30:53 -0400

WASHINGTON -- The FDA has issued a warning against use of the Mexican remedy Intestinomicina, which contains chloramphenicol, a potentially fatal ingredient that has been withdrawn from the market.

Burn Risk Seen with Topical Pain Relievers

Thu, 13 Sep 2012 13:23:30 -0400

WASHINGTON -- The FDA warned Thursday of the risks of rare but serious chemical burns with certain over-the-counter topical pain relievers, including Bengay, Capzasin, Flexall, Icy Hot, and Mentholatum.

FDA OKs PET Agent for Prostate Cancer

Wed, 12 Sep 2012 16:33:01 -0400

WASHINGTON -- The FDA has approved the positron emission tomography (PET) imaging agent Choline C 11 Injection for production and use in detecting recurrent prostate cancer.

FDA Warns About Sildenafil in Kids with PAH

Fri, 31 Aug 2012 15:01:48 -0400

The FDA has cautioned against using sildenafil (Revatio) to treat pulmonary arterial hypertension in children younger than 17, after an unexpectedly high rate of mortality in a clinical trial.

FDA OKs New Kids' Dose of Cancer Drug

Thu, 30 Aug 2012 17:04:08 -0400

WASHINGTON -- The FDA has approved a pediatric dosage of the cancer drug everolimus (Afinitor Disperz) for the treatment of a rare brain tumor.

FDA OKs Opioid for Diabetic Pain

Wed, 29 Aug 2012 16:11:51 -0400

WASHINGTON -- The FDA has approved the first opioid painkiller for neuropathic pain associated with diabetic peripheral neuropathy, according to the drug maker.

FDA OKs HIV 'Quad' Pill

Tue, 28 Aug 2012 14:25:50 -0400

WASHINGTON -- The FDA has approved Stribild, the four-drug combination of elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, for once-daily treatment of HIV in adults who have never received HIV treatment.